Department of Biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC) has announced approval from DCGI for emergency use authorization first of its kind intranasal COVID-19 Vaccine to Bharat Biotech (BBIL). Supported by DBT and BIRAC under the aegis of Mission COVID Suraksha, the mission was launched by DBT and implemented by BIRAC to reinforce and accelerate COVID-19 ...

Despite apprehensions on the sample numbers of human trials, Russia is preparing a mass vaccination campaign against the novel coronavirus in October, after a vaccine completed clinical trials including Phase III trial on Saturday, August 1, 2020. Health Minister Mikhail Murashko said the Gamaleya Institute, a state research facility in Moscow, had completed clinical trials preparing the required paperwork to ...

Any Covid-19 vaccine? All nations and the entire world humanity was eagerly awaiting the precious announcement from at least one top nation that its scientists have successfully completed clinical trials of Covid-19 vaccine. When expectations were running high that it would be China, where the novel coronavirus had its origin in the city of Wuhan, unexpectedly Russia has announced first ...

American pharmaceutical giant Pfizer has announced that its ongoing development of a COVID-19 vaccine could be ready in five months period by October end. Pfizer is working on the vaccine project in collaboration with German firm Biontech. Pfizer and its vaccine development German partner BioNTech announced on Friday, May 29, that the first participants have been given the doses in ...